Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain

Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
Conditions:   Chemotherapy-Induced Peripheral Neuropathy;   Malignant Neoplasm
Interventions:   Device: FitBit;   Other: Gait Assessment Test;   Other: MC5-A Scrambler Therapy;   Other: Quality-of-Life Assessment;   Procedure: Quantitative Sensory Testing;   Other: Questionnaire Administration
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 28, 2020 / by / in
Comments